{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T03:09:57Z","timestamp":1789873797784,"version":"4.0.1"},"reference-count":0,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurology"],"published-print":{"date-parts":[[1997,5]]},"DOI":"10.1212\/wnl.48.5.1421","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T13:29:01Z","timestamp":1336915741000},"page":"1421-1427","source":"Crossref","is-referenced-by-count":86,"title":["Albendazole therapy for neurocysticercosis"],"prefix":"10.1212","volume":"48","author":[{"given":"H. H.","family":"Garcia","sequence":"first","affiliation":[{"name":"From the Universidad Peruana Cayetano Heredia (Drs. Garcia, Gilman, Herrera, and Verastegui), Lima, Peru; the Instituto Nacional de Ciencias Neurologicas (Drs. Garcia, Gilman, Martinez, Altamirano, Cuba, and Rios-Saavedra), Lima, Peru, A. B. PRISMA (Drs. Garcia, Gilman, Boero, and Gonzalez), Lima, Peru; Johns Hopkins University (Dr. Gilman), Baltimore, MD, USA and SmithKline Beecham Pharmaceuticals (Dr. Horton), London, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. H.","family":"Gilman","sequence":"additional","affiliation":[{"name":"From the Universidad Peruana Cayetano Heredia (Drs. Garcia, Gilman, Herrera, and Verastegui), Lima, Peru; the Instituto Nacional de Ciencias Neurologicas (Drs. Garcia, Gilman, Martinez, Altamirano, Cuba, and Rios-Saavedra), Lima, Peru, A. B. PRISMA (Drs. Garcia, Gilman, Boero, and Gonzalez), Lima, Peru; Johns Hopkins University (Dr. Gilman), Baltimore, MD, USA and SmithKline Beecham Pharmaceuticals (Dr. Horton), London, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Horton","sequence":"additional","affiliation":[{"name":"From the Universidad Peruana Cayetano Heredia (Drs. Garcia, Gilman, Herrera, and Verastegui), Lima, Peru; the Instituto Nacional de Ciencias Neurologicas (Drs. Garcia, Gilman, Martinez, Altamirano, Cuba, and Rios-Saavedra), Lima, Peru, A. B. PRISMA (Drs. Garcia, Gilman, Boero, and Gonzalez), Lima, Peru; Johns Hopkins University (Dr. Gilman), Baltimore, MD, USA and SmithKline Beecham Pharmaceuticals (Dr. Horton), London, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Martinez","sequence":"additional","affiliation":[{"name":"From the Universidad Peruana Cayetano Heredia (Drs. Garcia, Gilman, Herrera, and Verastegui), Lima, Peru; the Instituto Nacional de Ciencias Neurologicas (Drs. Garcia, Gilman, Martinez, Altamirano, Cuba, and Rios-Saavedra), Lima, Peru, A. B. PRISMA (Drs. Garcia, Gilman, Boero, and Gonzalez), Lima, Peru; Johns Hopkins University (Dr. Gilman), Baltimore, MD, USA and SmithKline Beecham Pharmaceuticals (Dr. Horton), London, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Herrera","sequence":"additional","affiliation":[{"name":"From the Universidad Peruana Cayetano Heredia (Drs. Garcia, Gilman, Herrera, and Verastegui), Lima, Peru; the Instituto Nacional de Ciencias Neurologicas (Drs. Garcia, Gilman, Martinez, Altamirano, Cuba, and Rios-Saavedra), Lima, Peru, A. B. PRISMA (Drs. Garcia, Gilman, Boero, and Gonzalez), Lima, Peru; Johns Hopkins University (Dr. Gilman), Baltimore, MD, USA and SmithKline Beecham Pharmaceuticals (Dr. Horton), London, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Altamirano","sequence":"additional","affiliation":[{"name":"From the Universidad Peruana Cayetano Heredia (Drs. Garcia, Gilman, Herrera, and Verastegui), Lima, Peru; the Instituto Nacional de Ciencias Neurologicas (Drs. Garcia, Gilman, Martinez, Altamirano, Cuba, and Rios-Saavedra), Lima, Peru, A. B. PRISMA (Drs. Garcia, Gilman, Boero, and Gonzalez), Lima, Peru; Johns Hopkins University (Dr. Gilman), Baltimore, MD, USA and SmithKline Beecham Pharmaceuticals (Dr. Horton), London, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. M.","family":"Cuba","sequence":"additional","affiliation":[{"name":"From the Universidad Peruana Cayetano Heredia (Drs. Garcia, Gilman, Herrera, and Verastegui), Lima, Peru; the Instituto Nacional de Ciencias Neurologicas (Drs. Garcia, Gilman, Martinez, Altamirano, Cuba, and Rios-Saavedra), Lima, Peru, A. B. PRISMA (Drs. Garcia, Gilman, Boero, and Gonzalez), Lima, Peru; Johns Hopkins University (Dr. Gilman), Baltimore, MD, USA and SmithKline Beecham Pharmaceuticals (Dr. Horton), London, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Rios-Saavedra","sequence":"additional","affiliation":[{"name":"From the Universidad Peruana Cayetano Heredia (Drs. Garcia, Gilman, Herrera, and Verastegui), Lima, Peru; the Instituto Nacional de Ciencias Neurologicas (Drs. Garcia, Gilman, Martinez, Altamirano, Cuba, and Rios-Saavedra), Lima, Peru, A. B. PRISMA (Drs. Garcia, Gilman, Boero, and Gonzalez), Lima, Peru; Johns Hopkins University (Dr. Gilman), Baltimore, MD, USA and SmithKline Beecham Pharmaceuticals (Dr. Horton), London, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Verastegui","sequence":"additional","affiliation":[{"name":"From the Universidad Peruana Cayetano Heredia (Drs. Garcia, Gilman, Herrera, and Verastegui), Lima, Peru; the Instituto Nacional de Ciencias Neurologicas (Drs. Garcia, Gilman, Martinez, Altamirano, Cuba, and Rios-Saavedra), Lima, Peru, A. B. PRISMA (Drs. Garcia, Gilman, Boero, and Gonzalez), Lima, Peru; Johns Hopkins University (Dr. Gilman), Baltimore, MD, USA and SmithKline Beecham Pharmaceuticals (Dr. Horton), London, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Boero","sequence":"additional","affiliation":[{"name":"From the Universidad Peruana Cayetano Heredia (Drs. Garcia, Gilman, Herrera, and Verastegui), Lima, Peru; the Instituto Nacional de Ciencias Neurologicas (Drs. Garcia, Gilman, Martinez, Altamirano, Cuba, and Rios-Saavedra), Lima, Peru, A. B. PRISMA (Drs. Garcia, Gilman, Boero, and Gonzalez), Lima, Peru; Johns Hopkins University (Dr. Gilman), Baltimore, MD, USA and SmithKline Beecham Pharmaceuticals (Dr. Horton), London, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. E.","family":"Gonzalez","sequence":"additional","affiliation":[{"name":"From the Universidad Peruana Cayetano Heredia (Drs. Garcia, Gilman, Herrera, and Verastegui), Lima, Peru; the Instituto Nacional de Ciencias Neurologicas (Drs. Garcia, Gilman, Martinez, Altamirano, Cuba, and Rios-Saavedra), Lima, Peru, A. B. PRISMA (Drs. Garcia, Gilman, Boero, and Gonzalez), Lima, Peru; Johns Hopkins University (Dr. Gilman), Baltimore, MD, USA and SmithKline Beecham Pharmaceuticals (Dr. Horton), London, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Cysticercosis Working Group in Peru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.48.5.1421","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T10:03:42Z","timestamp":1711533822000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.48.5.1421"}},"subtitle":["A prospective double\u2010blind trial comparing 7 versus 14 days of treatment"],"short-title":[],"issued":{"date-parts":[[1997,5]]},"references-count":0,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1997,5]]}},"alternative-id":["10.1212\/WNL.48.5.1421"],"URL":"https:\/\/doi.org\/10.1212\/wnl.48.5.1421","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,5]]}}}